Study on the nanoemulsion of poorly soluble drugs stabilized by Organic-Inorganic Nanocomposite

Xinrui Ma,Wenqiang Sun,Xiaohui Wei,Suping Qian,Yuhong Xu
2013-01-01
Abstract:SUMMARY We designed a new synthesis method for a novel pmma/silica nanocomposites structure based on in situ emulsion polymerization. The nanocomposites were used to stabilize a nanoemulsion formulation for peroral delivery of poorly water soluble drugs. The loading capacity and physical stability of the nanoemulsion system were greatly improved. In addition, the formulation also helped with oral absorption and bioavailability. In conclusion, the nanoemulsion structure may be further developed into a new and promising oral formulation for water insoluble drugs. INTRODUCTION A surprisingly large proportion of new drug candidates emerging from drug discovery programmes are water insoluble, and therefore poorly bioavailable. It would be even difficult to even test the in vivo efficacy of these compounds, let alone develop them into successful drugs. Many attempts were made to overcome this problem, including various salt form screening, cyclodextrin inclusion, incorporation of co-solvents and etc. Emulsions, especially self emulsify drug delivery system (SEDDS) were found beneficial for the improvement of intestinal absorption. However most SEDDS formulations use a large amount of surfactants, which could lead to local irritation and even hemolysis. In many cases, even with a lot of surfactants, their stabilizing effect of the interface is still limited because the adsorption of small molecule surfactants in the oil-water interface is highly reversible. In this study, we developed a macromolecule and nanoparticle based emulsion stabilization system. The nanoemulsion doesn't need any small molecule surfactants. It is highly stable , and can even improve oral bioavailability of poorly water soluble drug significantly. EXPERIMENTAL METHODS The pmma/silica composites were prepared via in situ emulsion polymerization. 0.48g silica nanoparticles (Aerosil380 from Evonik Industries AG) were added to 20ml ultrapure water under vigorous magnetic stirring. After stirring for another 1h at room temperature, the mixture of 0.12g methacrylic acid and 0.084g ammonia, and 0.12g n-butyl methacrylate, 0.12g methyl methacrylate were added successively to the flask. The mixed solution was stirred with temperature rising to 80°C, then 0.019g ammonium persulfate was added to the solution. After10-15min, 1.332g of the same monomer mixture were added drop-wise into the system with stirring. The whole process lasted for 30min. Then, the system was maintained at 80°C for 1h to allow the reactions to be completed. The synthesized pmma/silica nanocomposites were used to prepare the nanoemulsion formulation. 2.4ml the nanocomposite solution was mixed with 0.6ml of corn oil, vortexed for 30s, and emulsified by ultrasounded for 10min. The following characterizations of composite particles and the nanoemulsion were carried out : PCS, TEM, stability etc. RESULTS AND DISCUSSION Silica/pmma nanocomposite particles were successfully prepared. The particle size, characterized by dynamic light scattering (DLS), was 107.4 ± 7.6 nm in diameter with monodistribution (the standard deviation here represents the half width of the particle size distribution). Figure 1 is a representative TEM image of the composite particles. The size demonstrated from the TEM is consistent with the PCS result. The nanocomposite stabilized nanoemulsion was prepared and TEM images of the emulsion droplets were shown in figure 2. The emulsion was still stable two months after prepared, and no phase separation occurred. Fig. 1. TEM images of pmma/silica nanocomposites Fig. 2. TEM images of emulsion stabilized by pmma/silica nanoparticles CONCLUSION In summary, pmma/silica nanocomposites were successfully synthesized via in situ emulsion polymerization. They can be used to stabilize nanoemulsions with distinctive properties for oral drug administration. REFERENCES 1. Rabinow, B., Nanosuspensions in drug deliv-ery. Nat Rev Drug Discov., 2004, 3 (9): p.785-96. 2. Fahr, A.; Liu, X., Drug delivery strategies for poorly water-soluble drugs. Expert opinion on drug delivery, 2007, 4 (4): p. 403-16. 3. Dunn, C.J., et al., Cyclosporin An updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral®) in organ transplantation. Drugs, 2001. 61(13): p. 1957-2016. 4. Prete, P., et al., Solubilization of human erythrocyte membranes by non-ionic surfactants of the polyoxyethylene alkyl ethers series. Biophysical chemistry, 2002. 97(1): p. 45-54. 5. Hall-Manning, T., et al., Skin irritation potential of mixed surfactant systems. Food and chemical toxicology, 1998. 36(3): p. 233-238. ACKNOWLEDGMENTS The work is being supported by NSFC 81274365.
What problem does this paper attempt to address?